Synthorx Announces Pricing of Initial Public Offering

World News: . []

SAN DIEGO Dec 06 2018 GLOBE NEWSWIRE -- Synthorx Inc (Nasdaq: THOR a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune disor ders, t...

More news and information about Synthorx, Inc.

Published By:

Globe Newswire: 02:15 GMT Friday 7th December 2018

Published: .

Search for other references to "synthorx" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us